$58M Opioid Deal Cuts Allergan, Teva From SF Bellwether Trial
San Francisco struck settlements worth almost $58 million with Allergan and Teva Pharmaceuticals on Tuesday in the sole ongoing trial over the pharmaceutical industry's role in a nationwide crisis of opioid...To view the full article, register now.
Already a subscriber? Click here to view full article